ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $27,000 | -63.0% | 15,064 | -55.5% | 0.00% | – |
| Q3 2021 | $73,000 | -22.3% | 33,825 | +26.2% | 0.00% | – |
| Q2 2021 | $94,000 | -66.4% | 26,807 | +3.8% | 0.00% | -100.0% |
| Q4 2020 | $280,000 | -70.5% | 25,819 | -71.9% | 0.00% | -84.6% |
| Q3 2020 | $948,000 | -26.5% | 92,037 | -17.8% | 0.01% | +62.5% |
| Q4 2019 | $1,290,000 | +17.9% | 111,971 | -44.2% | 0.01% | -20.0% |
| Q3 2019 | $1,094,000 | +559.0% | 200,668 | +1333.3% | 0.01% | +400.0% |
| Q2 2019 | $166,000 | -3.5% | 14,000 | -52.8% | 0.00% | -33.3% |
| Q1 2018 | $172,000 | +48.3% | 29,642 | -6.8% | 0.00% | +50.0% |
| Q3 2017 | $116,000 | +346.2% | 31,800 | +208.6% | 0.00% | +100.0% |
| Q2 2017 | $26,000 | -7.1% | 10,303 | -2.3% | 0.00% | 0.0% |
| Q1 2017 | $28,000 | – | 10,544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |